Leading the Way in Life Science Technologies

GEN Exclusives

More »

January 15, Vol. 34, No. 2

  • Columns

    • Ariana’s Analytics Aim at Predictive Power
    • Gail Dutton
    • Ariana Pharma exhaustively mines and analyzes multiparametric data (biochemical, genomic, proteomic, genetic, metabolic, imaging, clinical, etc) to identify patient responders and reduce clinical and drug development risks The process generates actionable information using fewer biomarker signatures than traditional data-mining methods, ... more »
    • Setting Sights on Ocular Disorders
    • Age-related macular degeneration (AMD) is one of the leading causes of blindness There are two forms of AMD—wet and dry Currently, the majority of therapeutics being developed are for wet AMD ( Figure ) The standard therapy for wet AMD ... more »